Cognex Corporation (CGNX) Stock Price & Analysis

Cognex Corporation (CGNX) closed at USD 54.6 on Thursday, October 22, 2026, down 5.94% on the day. The US market is currently closed (pre-market); this is not a live price.

The prior close was USD 58.05; the Oct 22, 2026 session ranged USD 54.14–56.63 on volume of 1,518,459 shares. Market capitalization is $9.19B, with a 52-week range of USD 34.6–72.88 (NMS). Source: Nexqual, retrieved October 23, 2026 at 08:40 UTC.

Also available as compact Markdown for AI agents: nexqual.com/CGNX.md

Key facts (CGNX)

• Last four reported quarters (through Jul 5, 2026): revenue $1.09B, net income $175M (16.1% margin), free cash flow $268M (SEC filings).
• Valuation: P/E 52.5x (avg 58.5x at the last 3 fiscal year-ends).
• 2 of 80 tracked superinvestors hold CGNX (13F, Q2 2026): 0 new, 1 added, 1 reduced, 0 unchanged.
• Insider open-market sales, last ~7 months: 4 Form 4 filings, $16.6M; 3 not under a Rule 10b5-1 plan ($15.0M); 0 by opportunistic insiders, 0 by routine insiders (three-year test, Cohen, Malloy & Pomorski 2012).
• Analysts: Buy (mean 2.05 on a 1–5 scale) (20 analysts), mean target USD 79.37 (range 60–92).
• Total return with dividends: 1Y +14.4% vs S&P 500 +14.9%; 5Y -33.6% vs S&P 500 +80.3%.
• Next earnings: 2026-11-04, EPS estimate USD 0.52, revenue estimate $314M.

Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (CGNX)

Fiscal years end Dec. EPS is split-adjusted.

Valuation (price ÷ last four quarters, through Jul 5, 2026) (CGNX)

P/E 52.5x · P/S 8.4x · P/FCF 34.2x · P/B 5.6x · FCF yield 2.92% · Earnings yield 1.90% · Dividend yield (paid, TTM) 0.61% · Buyback yield (TTM) 1.68%

P/E at fiscal year-ends: Dec 2025 53.2x, Dec 2024 58.3x, Dec 2023 63.9x.

Superinvestors (SEC 13F-HR, Q2 2026) (CGNX)

2 of 80 tracked investors hold CGNX. Each row is the investor's latest 13F; change is vs their prior-quarter share count.

Insider sales (SEC Form 4, open-market, last ~7 months) (CGNX)

1 of 4 under a Rule 10b5-1 trading plan (scheduled in advance). Unplanned sales were timed by the insider.

% of holdings sold = shares sold ÷ (shares sold + all holdings the insider reported on that Form 4, direct and through trusts).

Insider type follows Cohen, Malloy & Pomorski (Journal of Finance, 2012). An insider who traded the stock in the same calendar month in each of the past three years is a routine trader; one who traded in each of those years without such a pattern is an opportunistic trader. In their study, trades by opportunistic insiders predicted future returns and trades by routine insiders did not. Counts open-market purchases and sales only (SEC Form 4 codes P and S) by that insider in that company. Not investment advice.

Analysts (CGNX)

Consensus Buy (mean 2.05 on a 1–5 scale), 20 analysts; mean target USD 79.37 (low 60, high 92).

Rating changes, last 120 days:

Total return (dividends reinvested) (CGNX)

CGNX revenue by product line (quarter ended Jul 5, 2026)

CGNX revenue by region (quarter ended Jul 5, 2026)

As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).

CGNX suppliers, customers and competitors (named in its 10-K)

Quoted from the company's 10-K filed Feb 12, 2026.

CGNX customer concentration

In the period ended Dec 31, 2025, a single direct customer accounted for 15% of revenue, per the company's 10-K filed Feb 12, 2026. The company does not name it.

CGNX company outlook (results filed Aug 5, 2026)

• “Cognex issued third-quarter and full-year 2026 guidance; details are summarized in the tables below.”
• “Table 1: Third-Quarter 2026 Guidance (Dollars in millions, except per share amounts) Q3 2026 Guidance Q3 2025 Results Q3 2025 Results ex CP* Y/Y Change** Y/Y Change** ex CP* Revenue $300 - $320 $277 $264 +12% +17% Adj.”
• “EPS (diluted) 1 $0.50 - $0.54 $0.33 $0.28 +58% +86% Table 2: Full-Year 2026 Guidance (Dollars in millions, except per share amounts) 2026 Guidance 2025 Results 2025 Results ex CP* Y/Y Change** Y/Y Change** ex CP* Revenue $1,130 - $1,150 $994 $982 +15% +16% Adj.”

Quoted word-for-word from the SEC 8-K results press release.

CGNX analyst estimates and revisions

CGNX options: expected move

Options price a move of about ±16.6% (±$9.05) by Nov 20, 2026, which includes earnings on Nov 4, 2026. Over the last 8 reports the stock moved ±12.9% on average.

30-day implied volatility 67.5% vs 52.7% realized over the last 30 trading days. Put/call ratio (volume) 0.42. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.

Key Statistics (as of October 23, 2026 at 08:40 UTC)

Technical Analysis (CGNX)

Nexqual's technical model rates CGNX "SELL" based on 1 bullish and 5 bearish signals across 127 daily candles, as of October 23, 2026 at 08:40 UTC.

Analyst Ratings (CGNX)

Wall Street analysts rate CGNX "Buy" based on 20 analysts, with a mean price target of USD 79.37 (range USD 60–92), per Nexqual as of October 23, 2026 at 08:40 UTC.

Earnings (CGNX)

Recent Earnings History

Source: Nexqual, October 23, 2026 at 08:40 UTC.

Financials & Fundamentals (CGNX)

Source: Nexqual, October 23, 2026 at 08:40 UTC.

Financial Health Score (CGNX)

Nexqual rates Cognex Corporation's overall financial health "Solid" across five dimensions, as of October 23, 2026 at 08:40 UTC.

Ownership (CGNX)

Source: Nexqual, October 23, 2026 at 08:40 UTC.

Leadership (CGNX)

Cognex Corporation is led by Matthew Moschner, President, CEO & Director, per Nexqual as of October 23, 2026 at 08:40 UTC.

Major Backers & Investors (CGNX)

Notable institutional backers of Cognex Corporation include Invesco, Price (T.Rowe) Associates Inc, Pictet Asset Management Holding SA, according to Nexqual as of October 23, 2026 at 08:40 UTC.

Active Investors

Index Funds (Passive)

Source: Nexqual, October 23, 2026 at 08:40 UTC.

From Cognex Corporation's Latest SEC 10-K Filing (filed 2026-02-12)

Key Strengths & Strategy (as disclosed to the SEC)

• We incurred RD&E costs of approximately $139 million (14% of revenue), $140 million (15% of revenue), and $139 million (17% of revenue), for the years ended December 31, 2025, 2024, and 2023, respectively.
• We rely on our proprietary software technology and hardware designs, as well as the technical expertise, creativity, and knowledge of our personnel and third parties, to maintain our position as a leading provider of machine vision products.
• The logistics industry demands high-speed, efficient throughput combined with end-to-end supply chain traceability.
• We rely on the technical expertise, creativity, and knowledge of our personnel, and therefore, we utilize patent, trademark, copyright, and trade secret protection to maintain our competitive position and protect our proprietary rights in our products and technology.

Partnerships

• We continuously invest in and enhance our cybersecurity measures, including employee training, incident response planning, and collaboration with third-party experts, to attempt to mitigate these risks.

Legal & Regulatory Risks (Item 1A, quoted)

• Changes in laws or regulations relating to data privacy, data protection, or product security, or any actual or perceived failure by us to comply with such laws and regulations, could harm our business.
• Changes in laws or regulations relating to artificial intelligence, data usage, or automated technologies, or any actual or perceived failure to develop, deploy, or govern such technologies responsibly, could harm our business.
• Our Company may be subject to time-consuming and costly litigation or activist shareholder activities.

Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.

Peers & Related Stocks

Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 08:40 UTC. This page is informational and not investment advice.

For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt